1.C1q or IgA deposition in glomeruli of children with primary membranous nephropathy.
Ke XU ; Fang WANG ; Zhong Hua WANG ; Liu Yu SUN ; Yong YAO ; Hui Jie XIAO ; Xiao Yu LIU ; Bai Ge SU ; Xu Hui ZHONG ; Na GUAN ; Hong Wen ZHANG ; Jie DING
Chinese Journal of Pediatrics 2022;60(9):901-907
		                        		
		                        			
		                        			Objective: To assess the correlation of glomerular C1q or IgA deposition with clinical and pathological features of primary membranous nephropathy (PMN) in children. Methods: The clinical and pathological manifestations including (phospholipase A2 receptor, PLA2R) and IgG subclasses staining in renal biopsies, serum anti-PLA2R antibody and therapeutic response of 33 children diagnosed with PMN in Peking University First Hospital from December 2012 to December 2020 were retrospectively summarized and analyzed. According to results of PLA2R test and findings renal pathological, the patients were divided into PLA2R-related group and non-PLA2R-related group, typical MN group and atypical MN group, C1q deposit group and non-C1q deposit group, as well as IgA deposit group and non-IgA deposit group respectively. T-test, Mann-Whitney U test and Fisher's exact probability test were used for comparison between the groups. Results: Among the 33 children with PMN, there were 20 males and 13 females, of that the age of onset was 11 (8, 13) years, and 32 patients had nephrotic level proteinuria. Renal biopsies were performed at 4.6 (2.1, 11.6) months after onset, and 28 patients (85%) received glucocorticoid or immunosuppressive therapy prior to renal biopsy. There were 20 cases (61%) with PLA2R-related MN and 13 cases (39%) with non-PLA2R-related MN. Compared with the non-PLA2R-related group, the PLA2R-related group had an older age of onset (12 (10, 13) vs. 7 (3, 12) years, Z=-2.52, P=0.011), a lower preceding infection rate (45% (9/20) vs. 11/13, P=0.032) and lower spontaneous remission rate (0 vs. 4/13, P=0.017). Renal PLA2R positivity was significantly associated with predominant or co-deposition of IgG4 (13/17 vs. 5/15, P=0.031) and low albumin levels at renal biopsy ((25±6) vs. (29±7) g/L, t=2.14, P=0.041). There were 12 patients with typical PMN and 21 patients with atypical PMN, and no significant difference in clinical and pathological manifestations was found between these 2 groups (all P>0.05). There were 10 cases (32.3%) with glomerular C1q deposition, and their disease course before renal biopsy was significantly shorter than those without C1q deposition (1.8 (0.8, 5.9) vs. 6.0 (2.5, 22.3) months, Z=-2.27, P=0.023). Twelve cases (36.4%) had glomerular IgA deposition, and their course of disease,clinical and pathological manifestations were not significantly different from those without IgA deposition (all P>0.05). Conclusion: Glomerular C1q or IgA deposition may not affect the clinical manifestations, glomerular PLA2R and IgG subclasses staining pattern, or the response to treatment of PMN in children.
		                        		
		                        		
		                        		
		                        			Autoantibodies
		                        			;
		                        		
		                        			Child
		                        			;
		                        		
		                        			Complement C1q/metabolism*
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Glomerulonephritis, Membranous/drug therapy*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunoglobulin A/immunology*
		                        			;
		                        		
		                        			Immunoglobulin G
		                        			;
		                        		
		                        			Kidney Glomerulus
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Retrospective Studies
		                        			
		                        		
		                        	
2.Co-existing proteinase 3-antineutrophil cytoplasmic antibody-associated vasculitis with immunoglobulin A nephropathy.
Adem KUCUK ; Yalcin SOLAK ; Abduzhappar GAIPOV ; Sinan BAGCACI ; Hasan ESEN ; Suleyman TURK ; Recep TUNC
The Korean Journal of Internal Medicine 2016;31(1):194-196
		                        		
		                        			
		                        			No abstract available.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/*complications/diagnosis/drug therapy/immunology
		                        			;
		                        		
		                        			Antibodies, Antineutrophil Cytoplasmic/*blood
		                        			;
		                        		
		                        			Biomarkers/blood
		                        			;
		                        		
		                        			Biopsy
		                        			;
		                        		
		                        			Drug Therapy, Combination
		                        			;
		                        		
		                        			Fluorescent Antibody Technique
		                        			;
		                        		
		                        			Glomerulonephritis, IGA/*complications/diagnosis/drug therapy/immunology
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunosuppressive Agents/therapeutic use
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Myeloblastin/*immunology
		                        			;
		                        		
		                        			Treatment Outcome
		                        			
		                        		
		                        	
3.Microscopic polyangiitis with crescentic glomerulonephritis initially presenting as acute pancreatitis.
A Young CHO ; Byeong Gwan KIM ; Sang Sun KIM ; Seong Hee LEE ; Hong Shik SHIN ; Yeong Jin CHOI ; In O SUN
The Korean Journal of Internal Medicine 2016;31(2):403-405
		                        		
		                        			
		                        			No abstract available.
		                        		
		                        		
		                        		
		                        			Acute Disease
		                        			;
		                        		
		                        			Biopsy
		                        			;
		                        		
		                        			Fatal Outcome
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Fluorescent Antibody Technique
		                        			;
		                        		
		                        			Glomerulonephritis/*complications/diagnosis/drug therapy/immunology
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunosuppressive Agents/therapeutic use
		                        			;
		                        		
		                        			Microscopic Polyangiitis/*complications/diagnosis/drug therapy/immunology
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Pancreatitis/diagnosis/drug therapy/*etiology/immunology
		                        			;
		                        		
		                        			Treatment Outcome
		                        			
		                        		
		                        	
4.Efficacy and safety of tacrolimus vs. cyclophosphamide for idiopathic membranous nephropathy: A meta-analysis of Chinese adults.
Zhen-qiong LI ; Man-li HU ; Chun ZHANG ; Yu-mei WANG
Journal of Huazhong University of Science and Technology (Medical Sciences) 2015;35(5):623-628
		                        		
		                        			
		                        			The efficacy and safety of tacrolimus (TAC) and cyclophosphamide (CTX) in the treatment of idiopathic membranous nephropathy (IMN) were compared in Chinese adult patients using a meta- analysis of the available literatures. Randomized controlled clinical trials (RCTs) of the treatment of primary IMN with TAC or CTX combined with corticosteroids in the English databases PubMed, Embase and Cochrane, as well as Chinese databases, were searched. Qualified studies were subjected to quality assessment and meta-analysis. A total of 8 RCTs, including 359 Chinese patients, were included in the meta-analysis. The complete remission rate and overall remission rate in the TAC treatment group after 6 months of treatment were higher than those in the CTX treatment group. No significant difference in remission rate was found after 12 months of treatment. There was no significant difference in the adverse reaction between the two groups at the 6th or 12th months. TAC-based treatment was associated with a faster response than CTX at the 6th month, but there was no significant difference between the two groups at 12th month in Chinese adults. Further study is needed to evaluate the long-term efficacy and safety of this treatment regimen.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Asian Continental Ancestry Group
		                        			;
		                        		
		                        			Cyclophosphamide
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Glomerular Basement Membrane
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			Glomerulonephritis, Membranous
		                        			;
		                        		
		                        			drug therapy
		                        			;
		                        		
		                        			ethnology
		                        			;
		                        		
		                        			immunology
		                        			;
		                        		
		                        			pathology
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunosuppressive Agents
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Patient Safety
		                        			;
		                        		
		                        			Randomized Controlled Trials as Topic
		                        			;
		                        		
		                        			Tacrolimus
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Treatment Outcome
		                        			
		                        		
		                        	
5.Progress on the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
Chao WANG ; Huan LU ; Cui YANG ; Yuezhong LUO
Chinese Medical Journal 2014;127(10):1960-1963
OBJECTIVETo highlight current knowledge about M-type phospholipase A2 receptor (PLA2R) which is the first human autoantigen discovered in adult idiopathic membranous nephropathy.
DATA SOURCESRelevant articles published in English from 2000 to present were selected from PubMed. Searches were made using the terms "idiopathic membranous nephropathy, M-type PLA2R and podocyte."
STUDY SELECTIONArticles studying the role of M-type PLA2R in idiopathic membranous nephropathy were reviewed. Articles focusing on the discovery, detection and clinical observation of anti-PLA2R antibodies were selected.
RESULTSM-type PLA2R is a member of the mannose receptor family of proteins, locating on normal human glomeruli as a transmembrane receptor. The anti-PLA2R in serum samples from MN were primarily IgG4 subclass. Technologies applied to detect anti-PLA2R autoantibody are mainly WB, IIFT, ELISA and so on. Studies from domestic and overseas have identified a strongly relationship between circulating anti-PLA2R levels and disease activity.
CONCLUSIONRecent discoveries corresponding to PLA2R facilitate a better understanding on IMN pathogenesis and may provide a new tool to its diagnosis, differential diagnosis, risk evaluation, response monitoring and patient-specific treatment.
Animals ; Autoantigens ; metabolism ; Glomerulonephritis, Membranous ; immunology ; metabolism ; Humans ; Podocytes ; metabolism ; Receptors, Phospholipase A2 ; metabolism
6.Detection of serum food specific antibodies of 6 common foods in patients with IgA nephropathy.
Chaomin ZHOU ; Zhigang LIU ; Weiguo SUI ; Dongfeng GU ; Yongqiang LI ; Hequn ZOU
Journal of Southern Medical University 2014;34(3):419-422
OBJECTIVETo explore the relationship between the major allergens of 6 common allergic foods and IgA nephropathy.
METHODSA sensitive sandwich enzyme-linked immunosorbent assay (ELISA) was used to detect the serum levels of food-specific IgA1, IgG and IgE in 31 patients with IgA nephropathy and 80 healthy volunteers. All the patients were examined for a history of food allergy using a questionnaire.
RESULTSSerum levels of IgA1 and IgG against the major allergens of the 6 common allergic foods were significantly higher in patients with IgA nephropathy than in healthy volunteers (P<0.05). There was no detectable food-specific IgE antibodies in the two groups. No patients had a clear history of food allergy. All the patients with increased IgG levels specific to 4 or more foods simultaneously had proteinuria.
CONCLUSIONSSome foods especially the highly allergic ones may participate in the pathogenesis and progression of IgA nephropathy.
Adult ; Antibody Specificity ; Case-Control Studies ; Female ; Food Hypersensitivity ; classification ; immunology ; Glomerulonephritis, IGA ; blood ; immunology ; Humans ; Immunoglobulin A ; blood ; Immunoglobulin E ; blood ; Immunoglobulin G ; blood ; Male ; Young Adult
7.Urokinase, urokinase receptor, and plasminogen activator inhibitor-1 expression on podocytes in immunoglobulin A glomerulonephritis.
Ji Hye LEE ; Mee Hye OH ; Jae Seok PARK ; Gyoung Jae NA ; Hye Wook GIL ; Jong Oh YANG ; Eun Young LEE ; Sae Yong HONG
The Korean Journal of Internal Medicine 2014;29(2):176-182
		                        		
		                        			
		                        			BACKGROUND/AIMS: The purpose of this study was to investigate the expression of urokinase-type plasminogen activator (uPA), uPA receptor (uPAR), and plasminogen activator inhibitor (PAI)-1 on podocytes in immunoglobulin A (IgA) glomerulonephritis (GN). METHODS: Renal biopsy specimens from 52 IgA GN patients were deparaffinized and subjected to immunohistochemical staining for uPA, PAI-1, and uPAR. The biopsies were classified into three groups according to the expression of uPA and uPAR on podocytes: uPA, uPAR, and a negative group. The prevalences of the variables of the Oxford classification for IgA GN were compared among the groups. RESULTS: On podocytes, uPA was positive in 11 cases and uPAR was positive in 38 cases; by contrast, PAI-1 was negative in all cases. Expression of both uPA and uPAR on podocytes was less frequently accompanied by tubulointerstitial fibrosis. CONCLUSIONS: Our results suggest a possible protective effect of podocyte uPA/uPAR expression against interstitial fibrosis.
		                        		
		                        		
		                        		
		                        			Adolescent
		                        			;
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Atrophy
		                        			;
		                        		
		                        			Biological Markers/analysis
		                        			;
		                        		
		                        			Biopsy
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Fibrosis
		                        			;
		                        		
		                        			Glomerulonephritis, IGA/diagnosis/*enzymology/immunology
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunohistochemistry
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Plasminogen Activator Inhibitor 1/*analysis
		                        			;
		                        		
		                        			Podocytes/*enzymology/immunology/pathology
		                        			;
		                        		
		                        			Receptors, Urokinase Plasminogen Activator/*analysis
		                        			;
		                        		
		                        			Urokinase-Type Plasminogen Activator/*analysis
		                        			;
		                        		
		                        			Young Adult
		                        			
		                        		
		                        	
8.Predictive Value of Conjointly Examined IL-1ra, TNF-R I, TNF-R II, and RANTES in Patients with Primary Glomerulonephritis.
Journal of Korean Medical Science 2013;28(2):261-267
		                        		
		                        			
		                        			Interleukin-1 receptor antagonist (IL-1ra), tumor necrosis factor soluble receptors (sTNF-R) type I and II, and regulated upon activation, normal T-cell expressed and secreted (RANTES) play an important role in the modulation of primary glomerulonephritis (GN) course. The aim of the study was to assess whether pre-treatment measurements of IL-1ra, sTNF-R, and RANTES assessed conjointly may be useful as predicting factors in patients with GN. In 84 patients (45 males and 39 female) serum concentration (pg/mL) and urinary excretion (pg/mgCr) of cytokines were measured. After 12 months of therapy with steroids and cyclophosphamide the patients were divided into two subgroups: Responders (R) and Non-Responders (NR) according to the treatment results. The urinary IL-1ra, TNF-RI and RII were significantly higher in R than NR (1,732 vs 646 with P < 0.001, 13.1 vs 6.3 with P = 0.005, and 33.6 vs 14.4 with P = 0.012). The urinary RANTES excretion was increased in NR (79.6 vs 28.5; P < 0.001). The multivariable analysis showed that if conjointly assessed, only urinary IL-1ra, TNF-R I and R II, RANTES with 85% probability pointed the feature remission (R). In conclusion, the urinary excretion of IL-1ra, TNF-R I and R II, and RANTES examined conjointly are effective in predicting favorable response to immunosuppressive treatment in patients with GN.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Cyclophosphamide/therapeutic use
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Glomerulonephritis/drug therapy/*metabolism/pathology
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Immunosuppressive Agents/therapeutic use
		                        			;
		                        		
		                        			Interleukin 1 Receptor Antagonist Protein/*analysis/blood/urine
		                        			;
		                        		
		                        			Lymphocyte Activation
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Multivariate Analysis
		                        			;
		                        		
		                        			Predictive Value of Tests
		                        			;
		                        		
		                        			Receptors, Tumor Necrosis Factor, Type I/*analysis/blood/urine
		                        			;
		                        		
		                        			Receptors, Tumor Necrosis Factor, Type II/*analysis/blood/urine
		                        			;
		                        		
		                        			Steroids/therapeutic use
		                        			;
		                        		
		                        			T-Lymphocytes/immunology/metabolism
		                        			
		                        		
		                        	
9.Potential of renal pathology on refining syndrome typing of Chinese medicine in IgA nephropathy.
Jian-Jun LI ; Xiang-Mei CHEN ; Ri-Bao WEI
Chinese journal of integrative medicine 2013;19(2):92-97
OBJECTIVETo investigate the potential of renal pathological index as a differential diagnosis factor for Chinese medicine (CM) syndromes typing in IgA nephropathy (IgAN).
METHODSA total of 1,016 patients with IgAN was recruited from November 2001 to November 2004. All the signs and symptoms including picture of the tongue and pulse tracings were collected. All patients were typed according to the CM syndrome typing scheme for chronic primary glomerulopathy. The severity of glomerulus and tubulointerstitial lesions (mild, moderate-severe) were evaluated using lee's grading system and the Katafuchi score system.
RESULTSThe syndrome types transform in turn by deficiency of both the Spleen (Pi) and Lung (Fei) qi, deficiency of both qi and yin, deficiency of Liver (Gan) and Kidney (Shen) yin and deficiency of Spleen-Kidney (Shen) yang, with the aggravation of pathogenetic condition and that the manifestation of deficiency of qi clinically showed proliferative lesion of glomerular mesangium, while the glomerular sclerosis pathologically showed the manifestation of yin deficiency.
CONCLUSIONRenal pathological findings may be a candidate of objective factors to refine CM syndrome typing process.
Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Female ; Glomerulonephritis, IGA ; classification ; immunology ; pathology ; therapy ; Humans ; Kidney ; blood supply ; pathology ; Kidney Glomerulus ; pathology ; Male ; Medicine, Chinese Traditional ; Middle Aged ; Renal Artery ; pathology ; Syndrome ; Young Adult
10.Retrospective clinical features and renal pathological analysis of 15 children with anti-neutrophil cytoplasmic antibody-associated vasculitis.
Na GUAN ; Yong YAO ; Ji-Yun YANG ; Hui-Jie XIAO ; Jie DING
Chinese Journal of Pediatrics 2013;51(4):283-287
OBJECTIVEAnti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is a disorder with poor prognosis. This study aimed to improve the diagnosis and treatment of ANCA associated vasculitis of children, to analyze the clinical features, pathological characteristics and the prognosis of children with ANCA-associated vasculitis.
METHODFifteen children with ANCA associated vasculitis who were hospitalized from 2003 to 2012 in our hospital were included. Their data of pre-diagnosis status, clinical manifestations, renal pathology, treatment and prognosis were reviewed retrospectively.
RESULTOf the 15 children, 11 were girls and 4 boys with a mean age of 10.7 years. Fourteen children were categorized as microscopic polyangitis. The time to diagnosis varied from 0.5 month to 40 months. Hematuria and proteinuria were revealed by urine analysis in all of them, only 6 children complained with gross hematuria or edema of oliguria. Decreased glomerular filtration rate was revealed in 13 children, 8 of whom had a creatinine clearance rate of less than 15 ml/(min·1.73 m(2)). Twelve children underwent renal biopsy, crescent formation was found in 11 children. Most of the crescents were cellular fibrous crescents or fibrous crescents. Six children were diagnosed as crescentic nephritis; the process of rapidly progressive nephritis was only observed in 2 children. Segmental glomerulosclerosis or global glomerulosclerosis were found in 10 children, 3 of them were diagnosed as sclerotic glomerulonephritis. Anemia and pulmonary injury were the most common extra renal manifestations. Other extra renal manifestations included rash, pain joint, gastrointestinal symptoms, abnormal findings of cardiac ultrasonography and headache. Eight children were treated with steroid combined with cyclophosphamide, 4 were treated with steroid and mycophenolate mofetil, 2 were treated with steroid, cyclophosphamide and mycophenolate mofetil, 3 children were treated with plasma exchange. Fourteen children were followed up for 0.5 month to 4 years. The renal function did not recover in children with creatinine clearance rate of less than 30 ml/(min·1.73 m(2)), who showed crescentic glomerulonephritis or sclerotic glomerulonephritis. The children who had creatinine clearance rate of more than 30 ml/(min·1.73 m(2))had better prognosis.
CONCLUSIONMore attention should be paid to ANCA-associated vasculitis among school age girls with anemia or pulmonary diseases. The renal damage was serious in children; however, the clinical manifestations were not obvious. Children with a creatinine clearance rate of less than 30 ml/(min·1.73 m(2)) had poor prognosis. Early accurate diagnosis is very important.
Adolescent ; Anemia ; etiology ; pathology ; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis ; complications ; diagnosis ; pathology ; Antibodies, Antineutrophil Cytoplasmic ; blood ; immunology ; Biopsy ; Child ; Child, Preschool ; Creatinine ; blood ; Female ; Glomerulonephritis ; pathology ; Hematuria ; etiology ; pathology ; Humans ; Kidney ; pathology ; physiopathology ; Kidney Function Tests ; Male ; Nephritis ; diagnosis ; etiology ; pathology ; Prognosis ; Proteinuria ; etiology ; pathology ; Retrospective Studies
            
Result Analysis
Print
Save
E-mail